within the speedily evolving field of oncology investigate, precise and successful mutation screening is vital for acquiring specific therapies. The KRAS companies System performs a pivotal part In this particular landscape by supplying thorough answers for KRAS mutation profiling and Investigation. KRAS mutations, present in close to ninety five%